Advertisement

Heart and Vessels

, Volume 34, Issue 3, pp 435–441 | Cite as

Far-infrared therapy improves ankle brachial index in hemodialysis patients with peripheral artery disease

  • Chun-Fan Chen
  • Fu-An Chen
  • Ann Charis Tan
  • Tsung-Lun Lee
  • Chia-Hao Chan
  • Chih-Ching LinEmail author
Original Article

Abstract

Ankle brachial index (ABI) is a diagnostic tool for peripheral artery disease (PAD), which is an important issue in hemodialysis (HD) patients. We enrolled 198 maintenance HD patients in this study. PAD is defined as ABI ≤ 0.90. Only PAD patients received far-infrared (FIR) therapy using the WS TY101 FIR emitter for 40 min during each HD session, three times weekly for 6 months. The ABI was measured at the bilateral lower extremities for 4 times [pre-dialytic timing (0 min) and 40 min after the initiation of HD session at both day 0 and 6 months after the FIR therapy]. The primary outcome is the change in ABI. There were 51 out of 198 patients with PAD. In comparison with the period without FIR therapy in the 51 PAD patients, 6 months of FIR therapy significantly improved the ABI of the right/left side for 0 min (from 0.77 ± 0.19 to 0.81 ± 0.20, p = 0.027/0.79 ± 0.20 to 0.81 ± 0.17, p = 0.049), 40 min during HD (from 0.73 ± 0.23 to 0.83 ± 0.19, p < 0.001/from 0.77 ± 0.21 to 0.83 ± 0.18, p < 0.001), and the incremental change between 0 and 40 min (from − 0.04 ± 0.14 to 0.05 ± 0.13, p = 0.007/from − 0.05 ± 0.13 to 0.03 ± 0.11, p = 0.012), respectively. In conclusion, the application of FIR therapy for 40 min, three times weekly for 6 months, has improved the ABI of both lower extremities, thus providing a new strategy of PAD treatment in HD patients.

Keywords

Ankle brachial index (ABI) Far-infrared (FIR) therapy (FIRAPY) Hemodialysis (HD) Peripheral artery disease (PAD) End-stage renal disease (ESRD) 

Notes

Acknowledgements

This work was supported by intramural grants (V103C-043, V104C-026, V105C-075, V106C-036, and V107C-034) from Taipei Veterans General Hospital, and grants from the National Science Council (NSC101-2314-B-010-024-MY3) and the Ministry of Science and Technology (MOST 104-2314-B-010-032 -MY3) in Taiwan

Conflict of interest

None.

References

  1. 1.
    The United States Renal Data System (USRDS) (2017) Chapter 9: cardiovascular disease in patients With ESRD. Am J Kidney Dis 69:S465–S480CrossRefGoogle Scholar
  2. 2.
    Eggers PW, Gohdes D, Pugh J (1999) Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 56:1524–1533CrossRefGoogle Scholar
  3. 3.
    Gilhotra RA, Rodrigues BT, Vangaveti VN, Kan G, Porter D, Sangla KS, Malabu UH (2016) Non-traumatic lower limb amputation in patients with end-stage renal failure on dialysis: an Australian perspective. Ren Fail 38:1036–1043CrossRefGoogle Scholar
  4. 4.
    Sanchez Perales MC, Garcia Cortes MJ, Borrego Utiel FJ, Viedma G, Gil JM, Perez del Barrio P, Borrego Hinojosa J, Liebana A, Perez Banasco V (2005) Incidence and risk factors for non-traumatic lower extremity amputation in hemodialysis patients. Nefrologia 25:399–406Google Scholar
  5. 5.
    Arneja AS, Tamiji J, Hiebert BM, Tappia PS, Galimova L (2015) Functional outcomes of patients with amputation receiving chronic dialysis for end-stage renal disease. Am J Phys Med Rehabil 94:257–268CrossRefGoogle Scholar
  6. 6.
    Chen SC, Lee MY, Huang JC, Shih MC, Chang JM, Chen HC (2016) Association of ankle-brachial index and aortic arch calcification with overall and cardiovascular mortality in hemodialysis. Sci Rep 6:33164CrossRefGoogle Scholar
  7. 7.
    Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW, Satayathum S, Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D, Saran R (2006) Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114:1914–1922CrossRefGoogle Scholar
  8. 8.
    Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes FGR, Hiatt WR, Jonsson B, Lacroix P, Marin B, McDermott MM, Norgren L, Pande RL, Preux PM, Stoffers HE, Treat-Jacobson D (2012) Measurement and interpretation of the Ankle-Brachial Index: a scientific statement from the American Heart Association. Circulation 126:2890–2909CrossRefGoogle Scholar
  9. 9.
    Tanaka M, Ishii H, Aoyama T, Takahashi H, Toriyama T, Kasuga H, Takeshita K, Yoshikawa D, Amano T, Murohara T (2011) Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis. Atherosclerosis 219:643–647CrossRefGoogle Scholar
  10. 10.
    Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK (1996) Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 27:668–672CrossRefGoogle Scholar
  11. 11.
    Kitahara T, Ono K, Tsuchida A, Kawai H, Shinohara M, Ishii Y, Koyanagi H, Noguchi T, Matsumoto T, Sekihara T, Watanabe Y, Kanai H, Ishida H, Nojima Y (2005) Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 46:688–696CrossRefGoogle Scholar
  12. 12.
    Chen SC, Chang JM, Hwang SJ, Tsai JC, Liu WC, Wang CS, Lin TH, Su HM, Chen HC (2010) Ankle brachial index as a predictor for mortality in patients with chronic kidney disease and undergoing haemodialysis. Nephrology (Carlton) 15:294–299CrossRefGoogle Scholar
  13. 13.
    O'Hare AM, Hsu CY, Bacchetti P, Johansen KL (2002) Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 13:497–503Google Scholar
  14. 14.
    Ishii H, Kumada Y, Toriyama T, Aoyama T, Takahashi H, Tanaka M, Kamoi D, Kawamura Y, Yamada S, Hayashi M, Yasuda Y, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T (2010) Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: a retrospective chart review in Japanese patients. Clin Ther 32:24–33CrossRefGoogle Scholar
  15. 15.
    Ishii H, Kumada Y, Toriyama T, Aoyama T, Takahashi H, Yamada S, Yasuda Y, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T (2008) Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease. Clin J Am Soc Nephrol 3:1034–1040CrossRefGoogle Scholar
  16. 16.
    Koch M, Trapp R, Hepp W (2007) Impact of femoropopliteal bypass surgery on the survival and amputation rate of end-stage renal disease patients with critical limb ischemia. Med Klin (Munich) 102:107–111CrossRefGoogle Scholar
  17. 17.
    Rao A, Baldwin M, Cornwall J, Marin M, Faries P, Vouyouka A (2017) Contemporary outcomes of surgical revascularization of the lower extremity in patients on dialysis. J Vasc Surg 66:167–177CrossRefGoogle Scholar
  18. 18.
    Meyer A, Schinz K, Lang W, Schmid A, Regus S, Rother U (2016) Outcomes and influence of the pedal arch in below-the-knee angioplasty in patients with end-stage renal disease and critical limb ischemia. Ann Vasc Surg 35:121–129CrossRefGoogle Scholar
  19. 19.
    Davies MG, El-Sayed HF (2015) Outcomes of isolated tibial endovascular interventions for tissue loss in CLI patients on hemodialysis. J Endovasc Ther 22:681–689CrossRefGoogle Scholar
  20. 20.
    Graziani L, Silvestro A, Bertone V, Manara E, Alicandri A, Parrinello G, Manganoni A (2007) Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant 22:1144–1149CrossRefGoogle Scholar
  21. 21.
    Imamura M, Biro S, Kihara T, Yoshifuku S, Takasaki K, Otsuji Y, Minagoe S, Toyama Y, Tei C (2001) Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol 38:1083–1088CrossRefGoogle Scholar
  22. 22.
    Kihara T, Biro S, Ikeda Y, Fukudome T, Shinsato T, Masuda A, Miyata M, Hamasaki S, Otsuji Y, Minagoe S, Akiba S, Tei C (2004) Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure. Circ J 68:1146–1151CrossRefGoogle Scholar
  23. 23.
    Lin CC, Chang CF, Lai MY, Chen TW, Lee PC, Yang WC (2007) Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients. J Am Soc Nephrol 18:985–992CrossRefGoogle Scholar
  24. 24.
    Vatansever F, Hamblin MR (2012) Far infrared radiation (FIR): its biological effects and medical applications. Photonics Lasers Med 4:255–266Google Scholar
  25. 25.
    Yu SY, Chiu JH, Yang SD, Hsu YC, Lui WY, Wu CW (2006) Biological effect of far-infrared therapy on increasing skin microcirculation in rats. Photodermatol Photoimmunol Photomed 22:78–86CrossRefGoogle Scholar
  26. 26.
    Hatakeyama S, Saito M, Ishigaki K, Yamamoto H, Okamoto A, Ishibashi Y, Murasawa H, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C (2012) Skin perfusion pressure is a prognostic factor in hemodialysis patients. Int J Nephrol 2012:385274Google Scholar
  27. 27.
    Kipshidze N, Nikolaychik V, Muckerheidi M, Keelan MH, Chekanov V, Maternowski M, Chawla P, Hernandez I, Iyer S, Dangas G, Sahota H, Leon MB, Roubin G, Moses JW (2001) Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury model. Circulation 104:1850–1855CrossRefGoogle Scholar
  28. 28.
    Masuda A, Miyata M, Kihara T, Minagoe S, Tei C (2004) Repeated sauna therapy reduces urinary 8-epi-prostaglandin F(2alpha). Jpn Heart J 45:297–303CrossRefGoogle Scholar
  29. 29.
    Lin CC, Liu XM, Peyton K, Wang H, Yang WC, Lin SJ, Durante W (2008) Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler Thromb Vasc Biol 28:739–745CrossRefGoogle Scholar
  30. 30.
    Ikeda Y, Biro S, Kamogawa Y, Yoshifuku S, Eto H, Orihara K, Yu B, Kihara T, Miyata M, Hamasaki S, Otsuji Y, Minagoe S, Tei C (2005) Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in cardiomyopathic hamsters. Circ J 69:722–729CrossRefGoogle Scholar
  31. 31.
    Tronc F, Wassef M, Esposito B, Henrion D, Glagov S, Tedgui A (1996) Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 16:1256–1262CrossRefGoogle Scholar
  32. 32.
    Pipp F, Boehm S, Cai WJ, Adili F, Ziegler B, Karanovic G, Ritter R, Balzer J, Scheler C, Schaper W, Schmitz-Rixen T (2004) Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol 24:1664–1668CrossRefGoogle Scholar
  33. 33.
    Krishna S, Moxon J, Golledge J (2015) A review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci 16:11294–11322CrossRefGoogle Scholar
  34. 34.
    Nakabe N, Kokura S, Shimozawa M, Katada K, Sakamoto N, Ishikawa T, Handa O, Takagi T, Naito Y, Yoshida N, Yoshikawa T (2007) Hyperthermia attenuates TNF-alpha-induced up regulation of endothelial cell adhesion molecules in human arterial endothelial cells. Int J Hyperthermia 23:217–224CrossRefGoogle Scholar
  35. 35.
    Lin CC, Yang WC, Chen MC, Liu WS, Yang CY, Lee PC (2013) Effect of far infrared therapy on arteriovenous fistula maturation: an open-label randomized controlled trial. Am J Kidney Dis 62:304–311CrossRefGoogle Scholar
  36. 36.
    Adragao T, Pires A, Branco P, Castro R, Oliveira A, Nogueira C, Bordalo J, Curto JD, Prata MM (2012) Ankle–brachial index, vascular calcifications and mortality in dialysis patients. Nephrol Dial Transplant 27:318–325CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  • Chun-Fan Chen
    • 1
    • 2
  • Fu-An Chen
    • 1
    • 2
  • Ann Charis Tan
    • 3
  • Tsung-Lun Lee
    • 1
    • 3
  • Chia-Hao Chan
    • 1
    • 3
  • Chih-Ching Lin
    • 1
    • 3
    Email author
  1. 1.School of MedicineNational Yang-Ming UniversityTaipeiTaiwan
  2. 2.Division of Nephrology, Department of Internal MedicineNational Yang-Ming University HospitalYilanTaiwan
  3. 3.Division of Nephrology, Department of MedicineTaipei Veterans General HospitalTaipeiTaiwan

Personalised recommendations